RoMed Klinikum Rosenheim | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Enrolling by invitation	Phase 3	2026-10-06		NCT04905693
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis	Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, hypersensitivity pneumonitis, immune system disorder, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 2	2026-10-05		NCT06329401
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 3	2026-09-30		NCT07361510
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL	Community-Acquired Infections, Community-Acquired Pneumonia, DNA Virus Infections, Disease Attributes, Healthcare-Associated Pneumonia, Herpesviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, Skin Diseases, Viral, Skin and Connective Tissue Diseases, herpes simplex infectious disease, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection, viral infectious disease, viral pneumonia	Recruiting	Phase 3	2026-07-23		NCT06134492